Published in Life Sci on October 10, 1983
Further evaluation of the potential anxiolytic activity of imidazo[1,5-a][1,4]diazepin agents selective for α2/3-containing GABAA receptors. Pharmacol Biochem Behav (2017) 0.75
Peripheral anti-A beta antibody alters CNS and plasma A beta clearance and decreases brain A beta burden in a mouse model of Alzheimer's disease. Proc Natl Acad Sci U S A (2001) 5.60
Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor. Science (1986) 4.44
International Union of Pharmacology. XV. Subtypes of gamma-aminobutyric acidA receptors: classification on the basis of subunit structure and receptor function. Pharmacol Rev (1998) 4.37
Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition. Nat Genet (1997) 4.11
Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease. Proc Natl Acad Sci U S A (2000) 4.07
Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: guidelines for the prevention of antimicrobial resistance in hospitals. Clin Infect Dis (1997) 3.29
Symptom clusters and their effect on the functional status of patients with cancer. Oncol Nurs Forum (2001) 3.14
Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's disease. Proc Natl Acad Sci U S A (2001) 2.95
The revised Piper Fatigue Scale: psychometric evaluation in women with breast cancer. Oncol Nurs Forum (1998) 2.92
Psychophysiological insomnia: the behavioural model and a neurocognitive perspective. J Sleep Res (1997) 2.85
Lack of adherence with the analgesic regimen: a significant barrier to effective cancer pain management. J Clin Oncol (2001) 2.68
Stroke rehabilitation: analysis of repeated Barthel index measures. Arch Phys Med Rehabil (1979) 2.64
Stress-induced elevations of gamma-aminobutyric acid type A receptor-active steroids in the rat brain. Proc Natl Acad Sci U S A (1991) 2.50
Neurosteroids act on recombinant human GABAA receptors. Neuron (1990) 2.44
Apolipoprotein E is essential for amyloid deposition in the APP(V717F) transgenic mouse model of Alzheimer's disease. Proc Natl Acad Sci U S A (1999) 2.43
Binding of syndecan-like cell surface proteoglycan receptors is required for Neisseria gonorrhoeae entry into human mucosal cells. EMBO J (1995) 2.37
Nicotinic binding in rat brain: autoradiographic comparison of [3H]acetylcholine, [3H]nicotine, and [125I]-alpha-bungarotoxin. J Neurosci (1985) 2.37
Effects of xanomeline, a selective muscarinic receptor agonist, on cognitive function and behavioral symptoms in Alzheimer disease. Arch Neurol (1997) 2.35
Kappa-opioids produce significantly greater analgesia in women than in men. Nat Med (1996) 2.27
Expression of human apolipoprotein E reduces amyloid-beta deposition in a mouse model of Alzheimer's disease. J Clin Invest (1999) 2.21
Apolipoprotein E facilitates neuritic and cerebrovascular plaque formation in an Alzheimer's disease model. Ann Neurol (2000) 2.21
Functions of interleukin 1 receptor antagonist in gene knockout and overproducing mice. Proc Natl Acad Sci U S A (1996) 2.18
Memory-enhancing effects of secreted forms of the beta-amyloid precursor protein in normal and amnestic mice. Proc Natl Acad Sci U S A (1998) 2.00
Sleepwalking associated with zolpidem. J Clin Psychopharmacol (1994) 1.87
Functional antagonists at the NMDA receptor complex exhibit antidepressant actions. Eur J Pharmacol (1990) 1.82
Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: guidelines for the prevention of antimicrobial resistance in hospitals. Infect Control Hosp Epidemiol (1997) 1.82
The pharmacokinetics of lamivudine phosphorylation in peripheral blood mononuclear cells from patients infected with HIV-1. AIDS (1999) 1.78
Association of an interleukin 1 alpha polymorphism with Alzheimer's disease. Neurology (2000) 1.76
Receptors for the age of anxiety: pharmacology of the benzodiazepines. Science (1980) 1.76
Development and validation of the SDDS-PC screen for multiple mental disorders in primary care. Arch Fam Med (1995) 1.75
Root formation in ethylene-insensitive plants. Plant Physiol (1999) 1.70
N-methyl-D-aspartate antagonists limit aminoglycoside antibiotic-induced hearing loss. Nat Med (1996) 1.69
Differences in fear motivated behaviors among inbred mouse strains. Psychopharmacology (Berl) (1993) 1.67
An overview of chronic fatigue syndrome. J Clin Psychiatry (1991) 1.65
A randomized trial of exercise and dietary counseling after liver transplantation. Am J Transplant (2006) 1.61
Elevated brain concentrations of 1,4-benzodiazepines in fulminant hepatic failure. N Engl J Med (1991) 1.59
Behavioral history as a determinant of the effects of d-amphetamine on punished behavior. Science (1977) 1.57
A genome-wide search for chromosomal loci linked to bipolar affective disorder in the Old Order Amish. Nat Genet (1996) 1.56
Mapping quantitative trait loci for open-field behavior in mice. Behav Genet (1997) 1.54
Alprazolam augmentation of the antipsychotic effects of fluphenazine in schizophrenic patients. Preliminary results. Arch Gen Psychiatry (1988) 1.53
Physical functioning and health-related quality-of-life changes with exercise training in hemodialysis patients. Am J Kidney Dis (2000) 1.53
A selective imidazobenzodiazepine antagonist of ethanol in the rat. Science (1986) 1.53
Isolation and measurement of the endogenous cannabinoid receptor agonist, anandamide, in brain and peripheral tissues of human and rat. FEBS Lett (1996) 1.52
Effects of alcohol, chlordiazepoxide, cocaine and pentobarbital on responding maintained under fixed-interval schedules of food or shock presentation. J Pharmacol Exp Ther (1976) 1.51
Outbreak of Legionnaires' disease among cruise ship passengers exposed to a contaminated whirlpool spa. Lancet (1996) 1.50
Ethanol stimulates gamma-aminobutyric acid receptor-mediated chloride transport in rat brain synaptoneurosomes. Proc Natl Acad Sci U S A (1986) 1.45
A genome-wide search for chromosomal loci linked to mental health wellness in relatives at high risk for bipolar affective disorder among the Old Order Amish. Proc Natl Acad Sci U S A (1998) 1.45
Apolipoprotein E, amyloid, and Alzheimer disease. Mol Interv (2002) 1.42
Cloning and expression of a cDNA encoding a brain-specific Na(+)-dependent inorganic phosphate cotransporter. Proc Natl Acad Sci U S A (1994) 1.41
alpha2-Macroglobulin as a beta-amyloid peptide-binding plasma protein. J Neurochem (1997) 1.38
Brief diagnostic interviews (SDDS-PC) for multiple mental disorders in primary care. A pilot study. Arch Fam Med (1995) 1.37
Steroid hormone metabolites potentiate GABA receptor-mediated chloride ion flux with nanomolar potency. Eur J Pharmacol (1987) 1.36
The flower pot technique of rapid eye movement (REM) sleep deprivation. Pharmacol Biochem Behav (1975) 1.36
Linkage analyses of chromosome 18 markers do not identify a major susceptibility locus for bipolar affective disorder in the Old Order Amish. Am J Hum Genet (1995) 1.35
Comparison of in vitro activity and clinical pharmacology of doxycycline with other tetracyclines. Antimicrob Agents Chemother (Bethesda) (1966) 1.33
Punished behavior: increases in responding after d-amphetamine. Psychopharmacologia (1975) 1.33
The kappa opioid nalbuphine produces gender- and dose-dependent analgesia and antianalgesia in patients with postoperative pain. Pain (1999) 1.33
Synthesis, metabolism, and pharmacological activity of 3 alpha-hydroxy steroids which potentiate GABA-receptor-mediated chloride ion uptake in rat cerebral cortical synaptoneurosomes. J Med Chem (1990) 1.32
Intra- and interstrain differences in models of "behavioral despair". Pharmacol Biochem Behav (2001) 1.31
Insomnia, health-related quality of life and healthcare resource consumption. A study of managed-care organisation enrollees. Pharmacoeconomics (1998) 1.29
Behavioral disturbances in transgenic mice overexpressing the V717F beta-amyloid precursor protein. Behav Neurosci (1999) 1.29
The word-graphic rating scale as a measure of children's and adolescents' pain intensity. Res Nurs Health (1991) 1.29
Characterization of steroid interactions with gamma-aminobutyric acid receptor-gated chloride ion channels: evidence for multiple steroid recognition sites. Mol Pharmacol (1990) 1.29
Does my mouse have Alzheimer's disease? Genes Brain Behav (2002) 1.28
The relationship of presenting physical complaints to depressive symptoms in primary care patients. J Gen Intern Med (1993) 1.28
Behavior simultaneously maintained by both presentation and termination of noxious stimuli. J Exp Anal Behav (1978) 1.24
Phorbol esters inhibit agonist-induced [3H] inositol-1-phosphate accumulation in rat hippocampal slices. Biochem Biophys Res Commun (1984) 1.24
Activation of a caspase 3-related cysteine protease is required for glutamate-mediated apoptosis of cultured cerebellar granule neurons. Proc Natl Acad Sci U S A (1997) 1.24
Improving the recognition and management of depression: is there a role for physician education? J Fam Pract (1999) 1.23
Radioimmunoassay of 3 alpha-hydroxy-5 alpha-pregnan-20-one in rat and human plasma. Steroids (1990) 1.23
Prevalence of mental disorders in primary care. Implications for screening. Arch Fam Med (1995) 1.21
Sleeping pills, insomnia and medical practice. N Engl J Med (1979) 1.20
Identification of inosine and hypoxanthine as endogenous inhibitors of [3H] diazepam binding in the central nervous system. Life Sci (1978) 1.20
Sleep apnea syndrome in chronic renal disease. Am J Med (1989) 1.20
The experience of insomnia and daytime and nighttime functioning. Psychiatry Res (1984) 1.19
Antidepressant-like actions of an AMPA receptor potentiator (LY392098). Neuropharmacology (2001) 1.19
Conjunctive schedules of reinforcement II: response requirements and stimulus effects. J Exp Anal Behav (1975) 1.18
Minocycline blocks nitric oxide-induced neurotoxicity by inhibition p38 MAP kinase in rat cerebellar granule neurons. Neurosci Lett (2001) 1.17
Conjunctive schedules of reinforcement. I. Rate-dependent effects of pentobarbital and d-amphetamine. J Exp Anal Behav (1974) 1.16
N-methyl-D-aspartate induces a rapid, reversible, and calcium-dependent intracellular acidosis in cultured fetal rat hippocampal neurons. J Neurosci (1994) 1.15
Symptomatology of late-life minor depression among primary care patients. Psychosomatics (1990) 1.15
Characterization of benzodiazepine binding sites in cultured cells of neural origin. J Neurochem (1979) 1.14
Randomized clinical trial of the effectiveness of 3 commonly used mouthwashes to treat chemotherapy-induced mucositis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2000) 1.14
Adaptive changes in the N-methyl-D-aspartate receptor complex after chronic treatment with imipramine and 1-aminocyclopropanecarboxylic acid. J Pharmacol Exp Ther (1993) 1.13
Apolipoprotein E affects the amount, form, and anatomical distribution of amyloid beta-peptide deposition in homozygous APP(V717F) transgenic mice. Acta Neuropathol (2000) 1.13
Antidepressant effects of light in seasonal affective disorder. Am J Psychiatry (1985) 1.13
Characterization of benzodiazepine-sensitive behaviors in the A/J and C57BL/6J inbred strains of mice. Behav Genet (1994) 1.13
Prolonged sedation with propofol in the rat does not result in sleep deprivation. Anesth Analg (2001) 1.13
The role of primary care clinician attitudes, beliefs, and training in the diagnosis and treatment of depression. A report from the Ambulatory Sentinel Practice Network Inc. Arch Fam Med (1993) 1.13
Factors associated with cognitive recovery after cardiopulmonary resuscitation. Am J Crit Care (1996) 1.12
Anxiolytic activity of an endogenous adrenal steroid. Brain Res (1986) 1.12
Neuroinflammation-induced acceleration of amyloid deposition in the APPV717F transgenic mouse. Eur J Neurosci (2001) 1.11
Early regional cerebral glucose hypometabolism in transgenic mice overexpressing the V717F beta-amyloid precursor protein. Neurosci Lett (1999) 1.11
A rapid and sensitive radioreceptor assay for benzodiazepine in plasma. Arch Gen Psychiatry (1979) 1.11
Circulating levels of anxiolytic steroids in the luteal phase in women with premenstrual syndrome and in control subjects. J Clin Endocrinol Metab (1994) 1.10